To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01875705
Title A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Yale Cancer Center; Medical Oncology New Haven Connecticut 06520 United States Details
Karmanos Can Inst Detroit Michigan 48201 United States Details
Sarah Cannon Research Inst. Nashville Tennessee 37203 United States Details
Institut Gustave Roussy; Departement Oncologie Medicale Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field